Dosimetric effects of roll rotational setup errors on lung stereotactic ablative radiotherapy using volumetric modulated arc therapy

被引:11
作者
Lee, Jaegi [1 ,2 ]
Kim, Jung-In [2 ,3 ,4 ,5 ]
Ye, Sung-Joon [1 ,3 ]
Kim, Hak Jae [3 ,4 ,6 ]
Carlson, Joel [1 ,2 ]
Park, Jong Min [2 ,3 ,4 ,5 ]
机构
[1] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Transdisciplinary Studies, Program Biomed Radiat Sci, Seoul, South Korea
[2] Seoul Natl Univ, Coll Med, Biomed Res Inst, Seoul, South Korea
[3] Seoul Natl Univ Hosp, Dept Radiat Oncol, Seoul 110744, South Korea
[4] Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea
[5] Adv Inst Convergence Technol, Ctr Convergence Res Robot, Suwon, South Korea
[6] Seoul Natl Univ, Dept Radiat Oncol, Coll Med, Seoul, South Korea
关键词
BODY RADIATION-THERAPY; IMAGE-GUIDED RADIOTHERAPY; CONE-BEAM CT; CANCER; METASTASES; GUIDANCE; POSITION; PATIENT;
D O I
10.1259/bjr.20140862
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective: To evaluate the dosimetric effects of roll-rotational setup errors of stereotactic ablative radiotherapy (SABR) for lung cancer using volumetric modulated arc therapy (VMAT). Methods: A total of 23 lung SABR cases were evaluated retrospectively. Each of the planning CT images was intentionally rotated by +/- 1 degrees, +/- 2 degrees and +/- 3 degrees. After that, to simulate the translational couch correction, rotated CT images were moved along the x, y and z axis to match the centroid of the target volume in the rotated CT images with that in the original CT images. The differences in D-95% and V-100% of the target volume, D-0.35cc of spinal cord, D-0.35cc and D-5cc of oesophagus and V-20Gy of lung between the original and the rotated CT images were calculated. Results: The average differences in D95% and V100% of target volume, D0.35cc of spinal cord, D0.35cc and D5cc of oesophagus and V-20Gy of lung were -0.3% +/- 0.4% and -0.7% +/- 2.4%, 1.6 +/- 27.9 cGy, -1.6 +/- 37.6cGy, 15.9 +/- 25.3cGy and 0.0%+/- 0.1%, respectively. The dosimetric changes in organs at risk (OARs) near the target volume were sometimes considerable due to roll-rotational setup errors, despite the translational correction, and those were patient specific. Conclusion: In the case of coplanar VMAT for lung SABR, dosimetric changes to the target volume due to roll-rotational setup errors could be compensated by translational correction, whereas those to the OARs could not in some cases. Advances in knowledge: Roll-rotational setup errors would increase the dose to OARs despite the translational correction.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Optimizing the prescription isodose level in stereotactic volumetric-modulated arc radiotherapy of lung lesions as a potential for dose de-escalation
    Chan, Mark
    Wong, Matthew
    Leung, Ronnie
    Cheung, Steven
    Blanck, Oliver
    RADIATION ONCOLOGY, 2018, 13
  • [42] FEASIBILITY FOR USING HYPOFRACTIONATED STEREOTACTIC VOLUMETRIC MODULATED ARC RADIOTHERAPY (VMAT) WITH ADAPTIVE PLANNING FOR TREATMENT OF THYMOMA IN RABBITS: 15 CASES
    Dolera, Mario
    Malfassi, Luca
    Mazza, Giovanni
    Urso, Gaetano
    Sala, Massimo
    Marcarini, Silvia
    Carrara, Nancy
    Pavesi, Simone
    Finesso, Sara
    Kent, Michael S.
    VETERINARY RADIOLOGY & ULTRASOUND, 2016, 57 (03) : 313 - 320
  • [43] Flattening filter-free technique in volumetric modulated arc therapy for lung stereotactic body radiotherapy: A clinical comparison with the flattening filter technique
    Aoki, Shuri
    Yamashita, Hideomi
    Haga, Akihiro
    Nawa, Kanabu
    Imae, Toshikazu
    Takahashi, Wataru
    Abe, Osamu
    Nakagawa, Keiichi
    ONCOLOGY LETTERS, 2018, 15 (03) : 3928 - 3936
  • [44] Fractionated stereotactic radiotherapy of benign skull-base tumors: a dosimetric comparison of volumetric modulated arc therapy with Rapidarc® versus non-coplanar dynamic arcs
    Martin, Fanny
    Magnier, Florian
    Berger, Lucie
    Miroir, Jessica
    Chautard, Emmanuel
    Verrelle, Pierre
    Lapeyre, Michel
    Biau, Julian
    RADIATION ONCOLOGY, 2016, 11
  • [45] Dosimetric Evaluation at Volumetric Modulated Arc Therapy for Treatment of Prostate Cancer Using Single Or Double Arcs
    Silva, D.
    Salmon, H.
    Pavan, G.
    Nardi, S.
    Anderson, E.
    Fairbanks, L.
    Junior, J.
    Cursino, F.
    Colodette, K.
    MEDICAL PHYSICS, 2014, 41 (06) : 167 - +
  • [46] Simultaneous integrated boost radiotherapy for bilateral breast: a treatment planning and dosimetric comparison for volumetric modulated arc and fixed field intensity modulated therapy
    Nicolini, Giorgia
    Clivio, Alessandro
    Fogliata, Antonella
    Vanetti, Eugenio
    Cozzi, Luca
    RADIATION ONCOLOGY, 2009, 4
  • [47] Optimising Stereotactic Body Radiotherapy for Non-small Cell Lung Cancer with Volumetric Intensity-modulated Arc Therapy-A Planning Study
    Brock, J.
    Bedford, J.
    Partridge, M.
    McDonald, F.
    Ashley, S.
    McNair, H. A.
    Brada, M.
    CLINICAL ONCOLOGY, 2012, 24 (01) : 68 - 75
  • [48] RADIOLOGICAL AND CLINICAL PNEUMONITIS AFTER STEREOTACTIC LUNG RADIOTHERAPY: A MATCHED ANALYSIS OF THREE-DIMENSIONAL CONFORMAL AND VOLUMETRIC-MODULATED ARC THERAPY TECHNIQUES
    Palma, David A.
    Senan, Suresh
    Haasbeek, Cornelis J. A.
    Verbakel, Wilko F. A. R.
    Vincent, Andrew
    Lagerwaard, Frank
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 80 (02): : 506 - 513
  • [49] Optimizing SABR delivery for synchronous multiple lung tumors using volumetric-modulated arc therapy
    Tekatli, Hilal
    Tetar, Shyama U.
    Nguyen, Timothy K.
    Warner, Andrew
    Verbakel, Wilko F.
    Palma, David A.
    Dahele, Max
    Gaede, Stewart
    Haasbeek, Cornelis
    Spoelstra, Femke O.
    de Haan, Patricia F.
    Slotman, Ben J.
    Senan, Suresh
    ACTA ONCOLOGICA, 2017, 56 (04) : 548 - 554
  • [50] Rapid delivery of stereotactic radiotherapy for peripheral lung tumors using volumetric intensity-modulated arcs
    Verbakel, Wilko F. A. R.
    Senan, Suresh
    Cuijpers, Johan P.
    Slotman, Ben J.
    Lagerwaard, Frank J.
    RADIOTHERAPY AND ONCOLOGY, 2009, 93 (01) : 122 - 124